A compound represented by the formula (I):
its ester, their pharmaceutically acceptable salt or hydrate thereof and a pharmaceutical composition and a composition for inhibiting sPLA2 which contain the compound as an active ingredient.
由式(I)代表的化合物:
其酯、其药学上可接受的盐或
水合物,以及含有该化合物作为活性成分的药物组合物和抑制 sP
LA2 的组合物。